Option chain shows key data for Carl Zeiss Meditec's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Carl Zeiss Meditec.

Carl Zeiss Meditec (OTC:CZMWY) Stock, Option Chain

CARL ZEISS MEDITEC

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Analyst Color

Long Ideas

News

Short Ideas

Health Care

Initiation

Analyst Ratings

Movers

Trading Ideas

General

CZMWY

Innovation and digitalization have been in focus among ophthalmology majors.

Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: &#39;Innovation Is Key&#39;

Emerging Markets

Small Cap

Markets

TOPCF

Vision is the most cherished of the five senses. Losing your eyesight can have a tremendously debilitating impact on your day-to-day life.

24% of American Dont Have Vision Care: Here&#39;s Why

Tech

Image provided by Retina Technologies

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Technology That Could Catch Vision Problems Early And Save Your Eyesight?

CARL ZEISS MEDI UNSP/ADR by Carl Zeiss Meditec AG

Carl Zeiss Meditec AG

Press Releases

ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow

ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.

ZEISS introduces its latest Robotic Visualisation System for neuro surgery

ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach

ZEISS receives FDA clearance for INTRABEAM 700

ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone

ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care

CZMWF

Carl Zeiss Meditec

Comments

Carl Zeiss Meditec

Carl Zeiss Meditec (CZMWY) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell